NEJM AI: A New Frontier of Artificial Intelligence in Clinical Medicine

The New England Journal of Medicine (NEJM) is taking a significant step towards the future of healthcare by launching NEJM AI. This new, monthly, online-only publication will concentrate on evaluating the applications of artificial intelligence (AI) in clinical medicine. NEJM AI will also offer review articles, policy perspectives, and educational materials designed for both physicians and computer scientists. This revolutionary expansion comes as the medical field is experiencing a surge of investment and excitement around the rapid advancement of AI.

A New Era of Medicine: NEJM and AI

NEJM AI is a testament to the ever-growing influence of AI in the medical field. The launch of this online-only publication coincides with the increased focus on AI's generative capabilities, as demonstrated by applications like ChatGPT. The vision of AI significantly transforming areas of medical practice is becoming clearer every day. This new journal is NEJM's response to the rapid technological advancements and their potential applications in healthcare.

Collaborations for Advancements in Health Care

NEJM Catalyst and J-Med have also initiated a multiyear collaboration to spotlight advances in healthcare delivery in China. As part of this collaboration, they have published a supplemental issue focusing on healthcare delivery developments in China. The NEJM Catalyst Insights Council members emphasize the crucial role of multidisciplinary care and the assumption of financial risk in home-based care. NEJM Catalyst also offers dynamic, live-streamed web events featuring renowned experts and innovative thinkers providing solutions to the most pressing issues in healthcare delivery today. They also distribute a free weekly newsletter highlighting peer-reviewed content, live web events, and research reports from NEJM Catalyst Innovations in Care Delivery.

NEJM: Acknowledging Past Missteps and Driving Change

The New England Journal of Medicine is not just driving advancements in healthcare but also acknowledging its historical missteps. The Journal has launched a new series examining its own complicity in perpetuating slavery and its legacy in the United States. The series, authored by historians of medicine and physicians, highlights that NEJM's founders came from families that profited from slavery.

It also points out that the journal previously published articles that did not question the basic premise of health disparities. In the post-World War II period, there were more systematic incisive critiques, mostly by Black scholars and physicians, of the comparative approach to understanding the differences between races. NEJM is committed to interrogating their past actions seriously and making significant efforts to change medical theory and practice.

Conclusion

With the launch of NEJM AI, the New England Journal of Medicine is paving the way for the integration of AI in clinical medicine. As AI continues to rapidly evolve, NEJM AI will serve as a pivotal resource for physicians and computer scientists to keep abreast of the latest developments and applications in the medical field. Furthermore, NEJM's efforts to acknowledge and learn from its historical missteps provide a valuable lesson for all: progress is not just about technological advancements, but also about understanding and rectifying past mistakes.